chr9-97675236-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000380.4(XPA):​c.*203C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0502 in 680,894 control chromosomes in the GnomAD database, including 4,774 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 3070 hom., cov: 32)
Exomes 𝑓: 0.030 ( 1704 hom. )

Consequence

XPA
NM_000380.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.237

Publications

9 publications found
Variant links:
Genes affected
XPA (HGNC:12814): (XPA, DNA damage recognition and repair factor) This gene encodes a zinc finger protein plays a central role in nucleotide excision repair (NER), a specialized type of DNA repair. NER is responsible for repair of UV radiation-induced photoproducts and DNA adducts induced by chemical carcinogens and chemotherapeutic drugs. The encoded protein interacts with DNA and several NER proteins, acting as a scaffold to assemble the NER incision complex at sites of DNA damage. Mutations in this gene cause Xeroderma pigmentosum complementation group A (XP-A), an autosomal recessive skin disorder featuring hypersensitivity to sunlight and increased risk for skin cancer. [provided by RefSeq, Aug 2017]
XPA Gene-Disease associations (from GenCC):
  • xeroderma pigmentosum group A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-97675236-G-C is Benign according to our data. Variant chr9-97675236-G-C is described in ClinVar as [Benign]. Clinvar id is 364086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XPANM_000380.4 linkc.*203C>G 3_prime_UTR_variant Exon 6 of 6 ENST00000375128.5 NP_000371.1 P23025

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XPAENST00000375128.5 linkc.*203C>G 3_prime_UTR_variant Exon 6 of 6 1 NM_000380.4 ENSP00000364270.5 P23025
XPAENST00000462523.5 linkn.*461C>G non_coding_transcript_exon_variant Exon 7 of 7 5 ENSP00000433006.1 F2Z2T2
XPAENST00000485042.1 linkn.537C>G non_coding_transcript_exon_variant Exon 2 of 2 3
XPAENST00000462523.5 linkn.*461C>G 3_prime_UTR_variant Exon 7 of 7 5 ENSP00000433006.1 F2Z2T2

Frequencies

GnomAD3 genomes
AF:
0.119
AC:
18050
AN:
151946
Hom.:
3049
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.369
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.00404
Gnomad EAS
AF:
0.129
Gnomad SAS
AF:
0.0290
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00122
Gnomad OTH
AF:
0.0790
GnomAD2 exomes
AF:
0.0597
AC:
7744
AN:
129722
AF XY:
0.0501
show subpopulations
Gnomad AFR exome
AF:
0.369
Gnomad AMR exome
AF:
0.138
Gnomad ASJ exome
AF:
0.00741
Gnomad EAS exome
AF:
0.136
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000994
Gnomad OTH exome
AF:
0.0347
GnomAD4 exome
AF:
0.0303
AC:
16027
AN:
528830
Hom.:
1704
Cov.:
6
AF XY:
0.0264
AC XY:
7534
AN XY:
285758
show subpopulations
African (AFR)
AF:
0.366
AC:
5625
AN:
15378
American (AMR)
AF:
0.136
AC:
4542
AN:
33354
Ashkenazi Jewish (ASJ)
AF:
0.00728
AC:
137
AN:
18816
East Asian (EAS)
AF:
0.0968
AC:
2844
AN:
29380
South Asian (SAS)
AF:
0.0200
AC:
1226
AN:
61434
European-Finnish (FIN)
AF:
0.0000359
AC:
1
AN:
27868
Middle Eastern (MID)
AF:
0.0141
AC:
32
AN:
2276
European-Non Finnish (NFE)
AF:
0.000972
AC:
303
AN:
311574
Other (OTH)
AF:
0.0458
AC:
1317
AN:
28750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
696
1392
2088
2784
3480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.119
AC:
18127
AN:
152064
Hom.:
3070
Cov.:
32
AF XY:
0.117
AC XY:
8711
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.370
AC:
15321
AN:
41406
American (AMR)
AF:
0.113
AC:
1723
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00404
AC:
14
AN:
3468
East Asian (EAS)
AF:
0.129
AC:
671
AN:
5182
South Asian (SAS)
AF:
0.0290
AC:
140
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10578
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00122
AC:
83
AN:
68022
Other (OTH)
AF:
0.0791
AC:
167
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
610
1219
1829
2438
3048
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0583
Hom.:
229
Bravo
AF:
0.139
Asia WGS
AF:
0.107
AC:
374
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Xeroderma pigmentosum group A Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.82
DANN
Benign
0.46
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3176751; hg19: chr9-100437518; API